Klebsiellen-Leberabszess

Zusammenfassung

Klebsiellen-Leberabszesse (KLA) sind als abgegrenzte Eiteransammlung im Lebergewebe aufgrund einer Infektion mit gramnegativen Bakterien der Gattung Klebsiella definiert ([Abb. 1]). Als „emerging infections“ erlangen insbesondere hypervirulente Klebsiella pneumoniae (hvKP) der Kapsel-Serotypen 1 und 2 (K1, K2) weltweit eine zunehmende Bedeutung, da sie oft zu rezidivierenden Infektionen führen und schwer zu sanieren sind. Neben einer adäquaten Antibiotikatherapie bis zur vollständigen Abszessresolution müssen größere Abszesse invasiv behandelt werden. Das Auftreten multiresistenter hypervirulenter Klebsiellen-Stämme bereitet aufgrund der limitierten Therapieoptionen zunehmend Sorgen.

Abb. 1 Ultraschallbild eines Leberabszessrezidivs mit nachgewiesenen hypervirulenten Klebsiella pneumoniae (hvKP).

Publikationsverlauf

Artikel online veröffentlicht:
31. Juli 2023

• Literatur

• 1 Zhu J, Wang T, Chen L. et al. Virulence Factors in Hypervirulent Klebsiella pneumoniae. Front Microbiol 2021; 12: 642484
• 2 Lippmann N, Lübbert C, Kaiser T. et al. Clinical epidemiology of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2014; 14: 271-272
• 3 Viehweger A, Blumenscheit C, Lippmann N. et al. Context-aware genomic surveillance reveals hidden transmission of a carbapenemase-producing Klebsiella pneumoniae. Microb Genom 2021; 7
• 4 Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 1986; 146: 1913-1916
• 5 Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev 2019; 32 (03) e00001-e00019
• 6 Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae – clinical and molecular perspectives. J Intern Med 2020; 287: 283-300
• 7 Wang TC, Lin JC, Chang JC. et al. Virulence among different types of hypervirulent Klebsiella pneumoniae with multi-locus sequence type (MLST)-11, Serotype K1 or K2 strains. Gut Pathog 2021; 13: 40
• 8 Wendt S, Lübbert C, Karlas T. An Emerging Cause for Liver Abscesses With Poor Prognosis. Gastroenterology 2018; 155: e18-e19
• 9 Pichler C, Büchsel M, Rossen JW. et al. First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016. New Microbes New Infect 2017; 17: 77-80
• 10 Gu D, Dong N, Zheng Z. et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2018; 18: 37-46
• 11 Zimmermann L, Wendt S, Lübbert C. et al. Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance. United European Gastroenterol J 2021; 9: 1039-1047
• 12 Siu LK, Yeh KM, Lin JC. et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infectious Diseases 2012; 12: 881-887
• 13 Luo M, Yang XX, Tan B. et al. Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis. Eur J Clin Microbiol Infect Dis 2016; 35: 1557-1565
• 14 Mücke MM, Kessel J, Mücke VT. et al. The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses. BMC Infect Dis 2017; 17: 450
• 15 Bruns T, Stallmach A. Bakterielle hepatobiliäre Infektionen : Erregerspektrum, antimikrobielle Resistenzentwicklung und aktuelle Therapiekonzepte. Internist (Berl) 2022; 63: 349-366
• 16 Große K, Ohm D, Würstle S. et al. Clinical characteristics and outcome of patients with enterococcal liver abscess. Sci Rep 2021; 11: 22265
• 17 Yin D, Ji C, Zhang S. et al. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective study. Liver Int 2021; 41: 810-818
• 18 Tian LT, Yao K, Zhang XY. et al. Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clin Microbiol Infect 2012; 18: E314-30
• 19 Kong H, Yu F, Zhang W. et al. Clinical and microbiological characteristics of pyogenic liver abscess in a tertiary hospital in East China. Medicine (Baltimore) 2017; 96: e8050
• 20 Chen CH, Wu SS, Chang HC. et al. Initial presentations and final outcomes of primary pyogenic liver abscess: a cross-sectional study. BMC Gastroenterol 2014; 14: 133
• 21 Zhang S, Zhang X, Wu Q. et al. Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob Resist Infect Control 2019; 8: 166
• 22 Rahimian J, Wilson T, Oram V. et al. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 2004; 39: 1654-1659
• 23 Pang TCY, Fung T, Samra J. et al. Pyogenic liver abscess: an audit of 10 years' experience. World J Gastroenterol 2011; 17: 1622-1630
• 24 Lübbert C, Wiegand J, Karlas T. Therapy of Liver Abscesses. Viszeralmedizin 2014; 30: 334-341
• 25 Zou Q, Li Y. Hypervirulent Klebsiella pneumoniae. N Engl J Med 2021; 385: 833
• 26 Kunze G, Staritz M, Köhler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess. Ultrasound Med Biol 2015; 41: 952-959
• 27 Bielow T, Blank V, Opitz S. et al. Klebsiella Pneumoniae Liver Abscess Syndrome – A Challenge for Contrast-Enhanced Ultrasound. Ultrasound Int Open 2021; 7: E2-E5
• 28 Eisenmenger EF, Guajardo E, Finch N. et al. ‘String Test’ for Hypermucoviscous Klebsiella pneumoniae. Am J Med 2021; 134: e520-e521
• 29 Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes?. Virulence 2017; 8: 1111-1123
• 30 Gomi H, Solomkin JS, Schlossberg D. et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25: 3-16
• 31 Molton JS, Chan M, Kalimuddin S. et al. Oral vs Intravenous Antibiotics for Patients With Klebsiella pneumoniae Liver Abscess: A Randomized, Controlled Noninferiority Study. Clin Infect Dis 2020; 71: 952-959
• 32 Singh S, Chaudhary P, Saxena N. et al. Treatment of liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Ann Gastroenterol 2013; 26: 332-339
• 33 Rajak CL, Gupta S, Jain S. et al. Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. AJR Am J Roentgenol 1998; 170: 1035-1039
• 34 Yu SCH, Ho SSM, Lau WY. et al. Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Hepatology 2004; 39: 932-938
• 35 Czerwonko ME, Huespe P, Bertone S. et al. Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. HPB (Oxford) 2016; 18: 1023-1030